View in EDS HTML Full Text PDF Full Text

Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.

Saved in:
Bibliographic Details
Title: Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.
Authors: Sokolenko, Anna P.1,2 (AUTHOR) annasokolenko@mail.ru, Gorodnova, Tatiana V.3 (AUTHOR), Bizin, Ilya V.1 (AUTHOR), Kuligina, Ekaterina Sh.1 (AUTHOR), Kotiv, Khristina B.3 (AUTHOR), Romanko, Alexandr A.1 (AUTHOR), Ermachenkova, Tatiana I.1 (AUTHOR), Ivantsov, Alexandr O.1 (AUTHOR), Preobrazhenskaya, Elena V.1 (AUTHOR), Sokolova, Tatiana N.1 (AUTHOR), Broyde, Robert V.4 (AUTHOR), Imyanitov, Evgeny N.1,2,5 (AUTHOR)
Source: Cancer Chemotherapy & Pharmacology. Sep2021, Vol. 88 Issue 3, p439-450. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:03445704
DOI:10.1007/s00280-021-04301-6